Beerman Noah D

Avg. Two Year Performance

(47%) Avg. Purchase Return
(21%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return15%32%11%14%(47%)
Purchase Success Rate3 of 33 of 32 of 32 of 30 of 3
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

CEO and President, Director:

Holdings: 92.99K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Executive VP and COO:

Holdings: 15.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Executive Vice President:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--